Completed
Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer
NCT01607905
- Conditions
- Adenocarcinoma, Astrocytoma, Carcinoma, +28 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
- Gabrail Cancer Center Canton, Ohio, United States